Skip to main content

Prostatitis

1
Pipeline Programs
3
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
2100%
+ 2 programs with unclassified modality

Competitive Landscape

3 companies ranked by most advanced pipeline stage

AbbVie
AbbVieNORTH CHICAGO, IL
1 program
1
BotoxPhase 11 trial
Active Trials
NCT00529386Terminated7Est. Dec 2009
Ortho Development
2 programs
levofloxacinPHASE_3Small Molecule1 trial
levofloxacinPHASE_3Small Molecule1 trial
Active Trials
NCT00402688Completed242Est. Sep 2008
NCT00236808Completed383Est. Nov 2001
Bristol Myers Squibb
1 program
CC-10004PHASE_21 trial
Active Trials
NCT00701311Completed21Est. Mar 2011

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Ortho Developmentlevofloxacin
Ortho Developmentlevofloxacin
Bristol Myers SquibbCC-10004
AbbVieBotox

Clinical Trials (4)

Total enrollment: 653 patients across 4 trials

NCT00402688Ortho Developmentlevofloxacin

An Effectiveness and Safety Study for Levofloxacin in Chronic Prostatitis

Start: Nov 2006Est. completion: Sep 2008242 patients
Phase 3Completed
NCT00236808Ortho Developmentlevofloxacin

A Study to Evaluate the Safety and Effectiveness of Levofloxacin Compared With Ciprofloxacin in Patients With Chronic Bacterial Prostatitis

Start: May 2000Est. completion: Nov 2001383 patients
Phase 3Completed
NCT00701311Bristol Myers SquibbCC-10004

An Open-Label Study of CC-10004 for Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Start: Jun 2008Est. completion: Mar 201121 patients
Phase 2Completed
NCT00529386AbbVieBotox

Botox for Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)

Start: Jan 2006Est. completion: Dec 20097 patients
Phase 1Terminated

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.